Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2006-09, Vol.313 (5794), p.1785-1787
Hauptverfasser: Shaked, Yuval, Ciarrocchi, Alessia, Franco, Marcela, Lee, Christina R, Man, Shan, Cheung, Alison M, Hicklin, Daniel J, Chaplin, David, Foster, F. Stuart, Benezra, Robert, Kerbel, Robert S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1787
container_issue 5794
container_start_page 1785
container_title Science (American Association for the Advancement of Science)
container_volume 313
creator Shaked, Yuval
Ciarrocchi, Alessia
Franco, Marcela
Lee, Christina R
Man, Shan
Cheung, Alison M
Hicklin, Daniel J
Chaplin, David
Foster, F. Stuart
Benezra, Robert
Kerbel, Robert S
description The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.
doi_str_mv 10.1126/science.1127592
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68883949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>20031363</jstor_id><sourcerecordid>20031363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-c09b7f60cc59e5044a99d82af2ce029c6a02e97a6a993189446b588f83c1a9ce3</originalsourceid><addsrcrecordid>eNqFks1r3DAQxUVpabbbnntqKwrpzc3o09IxLGkSCCS0G3o0Wnm88WJbG8k-5L-vljUN5JKTGL3fPEZ6Q8hnBj8Z4_os-RYHj4eiVJa_IQsGVhWWg3hLFgBCFwZKdUI-pLQDyJoV78kJ09aCkmZB_q4fMLr9U3E91JPHmp77aUT6G32c2rHHYaShoas2-qlzYzts6cVQh_EBu9Z19C6GLQ7tGCJdYdclOga6nvoQ00fyrnFdwk_zuST3vy7Wq6vi5vbyenV-U3ilyrHwYDdlo8F7ZVGBlM7a2nDXcI_ArdcOONrS6XwvmLFS6o0ypjHCM2c9iiX5cfTdx_A4YRqrvk0-z-IGDFOqtDFGWGlfBYXOP1jC6yCzUlkpZAa_vwB3YYpDfm3F2cGu1DxDZ0fIx5BSxKbax7Z38aliUB0irOYIqznC3PF1tp02PdbP_JxZBk5nwCXvuia6wbfpmTNMGpUXYEm-HLldygH913neijyeyPq3o964ULltzB73fzgwAYyBZiDFP9-3tzM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213627762</pqid></control><display><type>article</type><title>Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors</title><source>American Association for the Advancement of Science</source><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Shaked, Yuval ; Ciarrocchi, Alessia ; Franco, Marcela ; Lee, Christina R ; Man, Shan ; Cheung, Alison M ; Hicklin, Daniel J ; Chaplin, David ; Foster, F. Stuart ; Benezra, Robert ; Kerbel, Robert S</creator><creatorcontrib>Shaked, Yuval ; Ciarrocchi, Alessia ; Franco, Marcela ; Lee, Christina R ; Man, Shan ; Cheung, Alison M ; Hicklin, Daniel J ; Chaplin, David ; Foster, F. Stuart ; Benezra, Robert ; Kerbel, Robert S</creatorcontrib><description>The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.1127592</identifier><identifier>PMID: 16990548</identifier><identifier>CODEN: SCIEAS</identifier><language>eng</language><publisher>Washington, DC: American Association for the Advancement of Science</publisher><subject>Angiogenesis inhibitors ; Angiogenesis Inhibitors - therapeutic use ; Animal tumors. Experimental tumors ; Animals ; Antibodies, Monoclonal - therapeutic use ; Antineoplastic Agents, Phytogenic - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Antineoplastics ; Biological and medical sciences ; Blood vessels ; Bone marrow ; Bone marrow cells ; Bone Marrow Cells - cytology ; Bone Marrow Cells - physiology ; Bones ; Cell Hypoxia ; Cell Line, Tumor ; Cells ; Diphosphates - therapeutic use ; Dosage ; Drug therapy ; Endothelial Cells - cytology ; Experimental tumors, general aspects ; Humans ; Hypoxia ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Mice, Nude ; Necrosis ; Neoplasm Transplantation ; Neoplasms, Experimental - blood supply ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - pathology ; Neovascularization, Pathologic ; Stem Cells - physiology ; Stilbenes - therapeutic use ; Tumors</subject><ispartof>Science (American Association for the Advancement of Science), 2006-09, Vol.313 (5794), p.1785-1787</ispartof><rights>Copyright 2006 American Association for the Advancement of Science</rights><rights>2006 INIST-CNRS</rights><rights>Copyright American Association for the Advancement of Science Sep 22, 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-c09b7f60cc59e5044a99d82af2ce029c6a02e97a6a993189446b588f83c1a9ce3</citedby><cites>FETCH-LOGICAL-c557t-c09b7f60cc59e5044a99d82af2ce029c6a02e97a6a993189446b588f83c1a9ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/20031363$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/20031363$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,2871,2872,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18148520$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16990548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaked, Yuval</creatorcontrib><creatorcontrib>Ciarrocchi, Alessia</creatorcontrib><creatorcontrib>Franco, Marcela</creatorcontrib><creatorcontrib>Lee, Christina R</creatorcontrib><creatorcontrib>Man, Shan</creatorcontrib><creatorcontrib>Cheung, Alison M</creatorcontrib><creatorcontrib>Hicklin, Daniel J</creatorcontrib><creatorcontrib>Chaplin, David</creatorcontrib><creatorcontrib>Foster, F. Stuart</creatorcontrib><creatorcontrib>Benezra, Robert</creatorcontrib><creatorcontrib>Kerbel, Robert S</creatorcontrib><title>Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.</description><subject>Angiogenesis inhibitors</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Animal tumors. Experimental tumors</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antineoplastic Agents, Phytogenic - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Antineoplastics</subject><subject>Biological and medical sciences</subject><subject>Blood vessels</subject><subject>Bone marrow</subject><subject>Bone marrow cells</subject><subject>Bone Marrow Cells - cytology</subject><subject>Bone Marrow Cells - physiology</subject><subject>Bones</subject><subject>Cell Hypoxia</subject><subject>Cell Line, Tumor</subject><subject>Cells</subject><subject>Diphosphates - therapeutic use</subject><subject>Dosage</subject><subject>Drug therapy</subject><subject>Endothelial Cells - cytology</subject><subject>Experimental tumors, general aspects</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Nude</subject><subject>Necrosis</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms, Experimental - blood supply</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Neovascularization, Pathologic</subject><subject>Stem Cells - physiology</subject><subject>Stilbenes - therapeutic use</subject><subject>Tumors</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks1r3DAQxUVpabbbnntqKwrpzc3o09IxLGkSCCS0G3o0Wnm88WJbG8k-5L-vljUN5JKTGL3fPEZ6Q8hnBj8Z4_os-RYHj4eiVJa_IQsGVhWWg3hLFgBCFwZKdUI-pLQDyJoV78kJ09aCkmZB_q4fMLr9U3E91JPHmp77aUT6G32c2rHHYaShoas2-qlzYzts6cVQh_EBu9Z19C6GLQ7tGCJdYdclOga6nvoQ00fyrnFdwk_zuST3vy7Wq6vi5vbyenV-U3ilyrHwYDdlo8F7ZVGBlM7a2nDXcI_ArdcOONrS6XwvmLFS6o0ypjHCM2c9iiX5cfTdx_A4YRqrvk0-z-IGDFOqtDFGWGlfBYXOP1jC6yCzUlkpZAa_vwB3YYpDfm3F2cGu1DxDZ0fIx5BSxKbax7Z38aliUB0irOYIqznC3PF1tp02PdbP_JxZBk5nwCXvuia6wbfpmTNMGpUXYEm-HLldygH913neijyeyPq3o964ULltzB73fzgwAYyBZiDFP9-3tzM</recordid><startdate>20060922</startdate><enddate>20060922</enddate><creator>Shaked, Yuval</creator><creator>Ciarrocchi, Alessia</creator><creator>Franco, Marcela</creator><creator>Lee, Christina R</creator><creator>Man, Shan</creator><creator>Cheung, Alison M</creator><creator>Hicklin, Daniel J</creator><creator>Chaplin, David</creator><creator>Foster, F. Stuart</creator><creator>Benezra, Robert</creator><creator>Kerbel, Robert S</creator><general>American Association for the Advancement of Science</general><general>The American Association for the Advancement of Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QQ</scope><scope>7QR</scope><scope>7SC</scope><scope>7SE</scope><scope>7SN</scope><scope>7SP</scope><scope>7SR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7TK</scope><scope>7TM</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>20060922</creationdate><title>Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors</title><author>Shaked, Yuval ; Ciarrocchi, Alessia ; Franco, Marcela ; Lee, Christina R ; Man, Shan ; Cheung, Alison M ; Hicklin, Daniel J ; Chaplin, David ; Foster, F. Stuart ; Benezra, Robert ; Kerbel, Robert S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-c09b7f60cc59e5044a99d82af2ce029c6a02e97a6a993189446b588f83c1a9ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Angiogenesis inhibitors</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Animal tumors. Experimental tumors</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antineoplastic Agents, Phytogenic - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Antineoplastics</topic><topic>Biological and medical sciences</topic><topic>Blood vessels</topic><topic>Bone marrow</topic><topic>Bone marrow cells</topic><topic>Bone Marrow Cells - cytology</topic><topic>Bone Marrow Cells - physiology</topic><topic>Bones</topic><topic>Cell Hypoxia</topic><topic>Cell Line, Tumor</topic><topic>Cells</topic><topic>Diphosphates - therapeutic use</topic><topic>Dosage</topic><topic>Drug therapy</topic><topic>Endothelial Cells - cytology</topic><topic>Experimental tumors, general aspects</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Nude</topic><topic>Necrosis</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms, Experimental - blood supply</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Neovascularization, Pathologic</topic><topic>Stem Cells - physiology</topic><topic>Stilbenes - therapeutic use</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaked, Yuval</creatorcontrib><creatorcontrib>Ciarrocchi, Alessia</creatorcontrib><creatorcontrib>Franco, Marcela</creatorcontrib><creatorcontrib>Lee, Christina R</creatorcontrib><creatorcontrib>Man, Shan</creatorcontrib><creatorcontrib>Cheung, Alison M</creatorcontrib><creatorcontrib>Hicklin, Daniel J</creatorcontrib><creatorcontrib>Chaplin, David</creatorcontrib><creatorcontrib>Foster, F. Stuart</creatorcontrib><creatorcontrib>Benezra, Robert</creatorcontrib><creatorcontrib>Kerbel, Robert S</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Ecology Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaked, Yuval</au><au>Ciarrocchi, Alessia</au><au>Franco, Marcela</au><au>Lee, Christina R</au><au>Man, Shan</au><au>Cheung, Alison M</au><au>Hicklin, Daniel J</au><au>Chaplin, David</au><au>Foster, F. Stuart</au><au>Benezra, Robert</au><au>Kerbel, Robert S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>2006-09-22</date><risdate>2006</risdate><volume>313</volume><issue>5794</issue><spage>1785</spage><epage>1787</epage><pages>1785-1787</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><coden>SCIEAS</coden><abstract>The contribution of bone marrow-derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.</abstract><cop>Washington, DC</cop><pub>American Association for the Advancement of Science</pub><pmid>16990548</pmid><doi>10.1126/science.1127592</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 2006-09, Vol.313 (5794), p.1785-1787
issn 0036-8075
1095-9203
language eng
recordid cdi_proquest_miscellaneous_68883949
source American Association for the Advancement of Science; Jstor Complete Legacy; MEDLINE
subjects Angiogenesis inhibitors
Angiogenesis Inhibitors - therapeutic use
Animal tumors. Experimental tumors
Animals
Antibodies, Monoclonal - therapeutic use
Antineoplastic Agents, Phytogenic - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Antineoplastics
Biological and medical sciences
Blood vessels
Bone marrow
Bone marrow cells
Bone Marrow Cells - cytology
Bone Marrow Cells - physiology
Bones
Cell Hypoxia
Cell Line, Tumor
Cells
Diphosphates - therapeutic use
Dosage
Drug therapy
Endothelial Cells - cytology
Experimental tumors, general aspects
Humans
Hypoxia
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Nude
Necrosis
Neoplasm Transplantation
Neoplasms, Experimental - blood supply
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - pathology
Neovascularization, Pathologic
Stem Cells - physiology
Stilbenes - therapeutic use
Tumors
title Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A41%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapy-Induced%20Acute%20Recruitment%20of%20Circulating%20Endothelial%20Progenitor%20Cells%20to%20Tumors&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Shaked,%20Yuval&rft.date=2006-09-22&rft.volume=313&rft.issue=5794&rft.spage=1785&rft.epage=1787&rft.pages=1785-1787&rft.issn=0036-8075&rft.eissn=1095-9203&rft.coden=SCIEAS&rft_id=info:doi/10.1126/science.1127592&rft_dat=%3Cjstor_proqu%3E20031363%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213627762&rft_id=info:pmid/16990548&rft_jstor_id=20031363&rfr_iscdi=true